LVTX icon

LAVA Therapeutics
LVTX

18 hedge funds and large institutions have $35.2M invested in LAVA Therapeutics in 2022 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 3 increasing their positions, 5 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

less ownership

Funds ownership: →

less funds holding

Funds holding: →

less capital invested

Capital invested by funds: $ → $

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 2

Holders
18
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$481K
2
+$4.48K
3
+$9

Top Sellers

1
-$758K
2
-$117K
3
-$9.56K
4
Morgan Stanley
Morgan Stanley
New York
-$6.54K
5
UBS Group
UBS Group
Switzerland
-$2.13K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$14.6M
2
$12.4M
3
$2.31M
4
$1.47M
5
$1.02M
6
$880K
7
$663K
8
$613K
9
$533K
10
$515K
11
$78K
12
$48K
13
$12K
14
$5K
15
$3K
16
$2K
17
–